Originally, it was our intention to produce a single-volume book covering all aspects and approaches to the problem of specific inhibitors of respiratory viruses. However, as the work progressed it became obvious that certain chapters, because of the research interests of the authors, concentrated particularly on influenza viruses. It seemed logical therefore, to divide the book into two volumes, the first emphasizing influenza and the second concentrating on other viruses as well as discussing important general aspects of drug screening and clinical testing, although the second volume does have some chapters which deal mainly with influenza.
1. Animal Models of Influenza Virus Infection as Applied to the Investigation of Antiviral Compounds 2. The Study of Antiviral Compounds in Volunteers 3. Clinical Testing of Antiviral Compounds on a Large Scale in General Practice 4. The Strategy of the Picornavirus Genome- Some Implications for Chemotherapy 5. The Coronaviruses 6. The Discovery and Development of Antiviral Drugs � The Commercial Approach 7. The Potential of Interferon and Interferon Inducers 8. Some New Approaches to Antiviral Chemotherapy, Metalloenzyme Inhibition, and Transport by Liposomes